MICRAMED

Executive Summary

MICRAMED is a UK-based consultancy specializing in microbiology and quality assurance services for the pharmaceutical, medical device, and cosmetic industries. Founded in 2017, the firm leverages over 23 years of combined industry experience to help clients navigate regulatory standards such as ISO 13485, ISO 17025, and GMP. Its service offerings include regulatory compliance support, laboratory project management, and R&D consulting, positioning it as a niche partner for companies requiring specialized microbiological expertise. As a private, service-oriented company, MICRAMED operates with a lean model, focusing on advisory and project-based engagements rather than product development or manufacturing. The consultancy's market position is supported by its deep domain knowledge and established presence in the UK life sciences ecosystem. While the company does not disclose financials or have publicly traded securities, its relevance stems from the increasing regulatory complexity and quality demands in regulated industries. Growth prospects are tied to expanding its client base and potentially broadening into new geographies or complementary services. However, as a small firm with no disclosed funding rounds or major commercial products, its scalability and revenue visibility remain limited. The company's profile suggests a stable but modest business with gradual growth opportunities, primarily dependent on client acquisition and retention.

Upcoming Catalysts (preview)

• Q4 2026New ISO 17025 Accreditation or Renewal70% success
• TBDMajor Contract Win with Pharmaceutical Client40% success